Canada Markets closed

Tekla Healthcare Opportunities Fund (THQ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
21.94-1.21 (-5.23%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close23.15
Open23.17
Bid21.00 x 800
Ask24.77 x 800
Day's Range21.68 - 23.20
52 Week Range20.01 - 25.92
Volume256,379
Avg. Volume71,063
Market Cap907.096M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.35 (5.42%)
Ex-Dividend DateDec. 17, 2021
1y Target EstN/A
  • Business Wire

    Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

    BOSTON, January 10, 2022--On January 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is January 20, 2022 and the payable date is January 31, 2022. The Fund will trade ex-distribution on January 19, 2022.

  • Business Wire

    Tekla Life Sciences Investors Paid Distribution

    BOSTON, December 31, 2021--On December 31, 2021, Tekla Life Sciences Investors paid a distribution of $0.42 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of t

  • Business Wire

    Tekla World Healthcare Fund Paid Distribution

    BOSTON, December 31, 2021--On December 31, 2021, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized loss